In a Pfizer-sponsored satellite meeting at the Latest Advances in Psychiatry Symposium in London in March, Dr David Baldwin, Reader in Psychiatry and Honorary Consultant Psychiatrist at University of Southampton, reviewed the drug treatment of generalised anxiety disorder. Medical writer, Mark Greener, reports. Copyright © 2009 Wiley Interface Ltd